Newsletters
ePaper
Sign in
Home
India
Assembly Polls 2024
Karnataka
Opinion
World
Business
Sports
Entertainment
Video
News Shots
Explainers
Bengaluru
Science
Trending
Photos
Brandspot
DH Specials
Home
News Shots
Trending
Menu
×
ADVERTISEMENT
ADVERTISEMENT
Novartis
Novartis breast cancer drug helped delay return of disease
Novartis’ Kisqali reduced the risk of breast cancer recurrence by 28.5 per cent in a four-year follow-up of patients with certain early types of the illness, according to data presented Monday at the European Society for Medical Oncology in Barcelona.
16 September 2024, 10:27 IST
Novartis breast cancer drug helped delay return of disease
16 September 2024, 10:27 IST
Bausch + Lomb to buy Novartis eye drop for $1.75 bn
Acquisition of the drug, Xiidra, will mark the first big deal by CEO Brent Saunders since he returned to the company in March.
30 June 2023, 13:10 IST
Bausch + Lomb to buy Novartis eye drop for $1.75 bn
30 June 2023, 13:10 IST
India's cardiac sector in for major disruptions: Report
With the drug going off patent, many pharmaceutical companies have jumped on the chance to market generic versions of the drug
04 December 2022, 09:46 IST
India's cardiac sector in for major disruptions: Report
04 December 2022, 09:46 IST
First-ever licencing deal struck for cancer drug
Novartis president of global health and sustainability Lutz Hegemann said the company was proud to be pioneering this new licensing model with MPP
20 October 2022, 10:07 IST
First-ever licencing deal struck for cancer drug
20 October 2022, 10:07 IST
Novartis slashes 8,000 jobs worldwide
The company aims to simplify its structure, among other things gathering oncology and other pharmaceutical activities in a single division
29 June 2022, 09:10 IST
Novartis slashes 8,000 jobs worldwide
29 June 2022, 09:10 IST
Novartis sells voting stake sale to Roche for $20.7 bn
The deal extricates Roche from ownership ties to a major competitor with strategic vetoing power
04 November 2021, 14:16 IST
Novartis sells voting stake sale to Roche for $20.7 bn
04 November 2021, 14:16 IST
Novartis says may divest generic drugs unit Sandoz
Third-quarter operating profit, adjusted for special items, rose 10% to $4.47 billion, driven by higher sales of arthritis and psoriasis drug Cosentyx
26 October 2021, 10:40 IST
Novartis says may divest generic drugs unit Sandoz
26 October 2021, 10:40 IST
Novartis signs deal to produce Pfizer-BioNTech vaccine
The financial terms of the agreement were not disclosed
21 October 2021, 10:29 IST
Novartis signs deal to produce Pfizer-BioNTech vaccine
21 October 2021, 10:29 IST
'4 more Indian firms may soon start vaccine production'
Even 7 to 9 per cent of the doses that remain unutilised by private hospitals are being used by the government vaccination centres, he added
03 August 2021, 11:19 IST
'4 more Indian firms may soon start vaccine production'
03 August 2021, 11:19 IST
Novartis India Q4 net profit rises 43% to Rs 9.7 crore
Revenue from operations stood at Rs 99.29 crore as compared to Rs 93.7 crore in the year-ago quarter
17 June 2021, 15:07 IST
Novartis India Q4 net profit rises 43% to Rs 9.7 crore
17 June 2021, 15:07 IST
<
1
2
3
>
